[Media coverage] Bill & Melinda Gates Foundation invests in Smart Immune's new clinical trial

Smart Immune's recent announcement on the Bill & Melinda Gates Foundation investment has been featured in several media.

‍

Financial Times: Gates Foundation makes unusual investment in experimental cancer trial

Fortune: An experimental cancer trial in France is getting a boost from the Gates Foundation: ‘Potential game-changer’

Endpoints: Smart Immune picks up $5M from Gates Foundation

Pharmaceutical Technology: Smart Immune secures funding from Bill & Melinda Gates Foundation

Reuters: Paris-headquartered company Smart Immune gets $5 mln investment from Bill & Melinda Gates Foundation

‍

Le Figaro (France): La Fondation Gates mise sur une biotech française

Les Echos (France): Bill Gates et sa fondation misent sur la biotech française Smart Immune

Challenges (France): Smart Immune : cette biotech française qui a séduit Bill Gates

BFM Business (France): Que fait Smart Immune, la biotech Française qui a Séduit La Fondation de Bill Gates? (live TV interview)

Usine Nouvelle (France) : «Pour la Fondation Gates, notre technologie est totalement disruptive», se félicite Karine Rossignol, DG de Smart Immune

CFNews (France): Smart Immune s’arme pour relancer le système immunitaire

CNET (France): Pourquoi la fondation de Bill Gates investit-elle dans cette biotech française?

Presse Citron (France): Cancer: Bill Gates dit oui à un essai expérimental français (et le finance)

‍

Il Sussidiario (Italy): Bill Gates investe in cure sperimentali anti cancro eHIV/ 5 milioni per Smart Immune

‍

Business Insider (Spain): La Fundación Gates invierte 5 millones de dólares en un ensayo experimental contra cáncer y el VIH

‍

‍